ConcentricLife provides companies in the biopharma industry with marketing expertise in rare diseases, healthcare and wellness. Financial terms of the transaction, which is still subject to closing conditions, were not disclosed in the Oct. 25 Accenture news release.
Through the acquisition, ConcentricLife’s more than 270 employees will become part of Accenture.
“Our shared ambition has always been to change the way health is experienced. This transaction will enhance our ability to help our clients achieve this vision in addressing the challenges of tomorrow,” ConcentricLife CEO Ken Begasse Jr. said in the news release. “With this combined talent of diverse thinking and experiences, we will extend our ability to solve new patient and provider challenges in high-impact areas including access, clinical trials, and patient services.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
